Farallon Capital Partners L.P. 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 5:11 pm Sale | 2023-12-31 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners L.P. | 6,750,204 4.100% | -12,276 (-0.18%) | Filing |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | Revolution Medicines, Inc. RVMD | Farallon Capital Partners L.P. | 6,762,480 6.200% | 6,762,480 (New Position) | Filing |